ChinaChinese dental implant manufacturer founded in 2007, part of BASS Medical Group. The company is headquartered in China with international branches in Germany, Canada, Australia, and China. Bioconcept offers two primary implant systems (BV and BC) and is sold in over 60 countries with over 1,000,000 implants placed worldwide.
Bioconcept was founded in 2007 by Yang Libo, who serves as Founder and CEO of BASS Medical Group. Mr. Yang has 30+ years of management experience, including working for Johnson & Johnson, Schlumberger, and PetroChina, and was formerly CEO of Kanghui Orthopedics and Vice President of Medtronic.
The company launched its BC System in 2009, receiving CE certification and entering the EU market.
Bioconcept received CFDA certification in 2010, becoming one of the first China-approved implant systems.
The company received TGA approval in Australia and CMDCAS certification in 2012, followed by FDA 510(k) clearance for the BC System in 2015.
Bioconcept launched the BV System and CAD/CAM solutions in 2017, and received FDA 510(k) clearance for the BV System in 2020 along with MDSAP certification.
The company reached 1,000,000+ implants placed globally by 2022, and completed its new production facility in 2023.
Bioconcept utilizes Grade 4 Titanium from ZAPP and S-L-A surface treatment technology, with state-of-the-art production facilities spanning 25,000 m².
Manufacturers whose components are recorded as fitting Bioconcept systems. The number is how many of its 7 systems list that brand.
China
